Search research articles
Contact Us
Filters
Showing results (81-90 of 153) with videos related to
Page
of 16
Sort By:
Statistics in Medicine
|
April 29, 1998
Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data
J Bernhard, H F Peterson, A S Coates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1994
First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research
M Borner, M Bacchi, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group
C Hürny, J Bernhard, A Coates, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group
C Hürny, J Bernhard, R D Gelber, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 26, 1999
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK)
J Bernhard, M Castiglione-Gertsch, S F Schmitz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 20, 1999
Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group
M Colleoni, K Price, M Castiglione-Gertsch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 1999
Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: the SAKK experience. Swiss Group for Clinical Cancer Research (SAKK)
A D Roth, R Herrmann, R Morant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?
J Bernhard, B Thürlimann, S F Schmitz, et al.
Biological Psychiatry
|
March 15, 1996
No association between alcoholism and multiple polymorphisms at the dopamine D2 receptor gene (DRD2) in three distinct Taiwanese populations
R B Lu, H C Ko, F M Chang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1996
First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88
B Thürlimann, K Beretta, M Bacchi, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 153) with videos related to
Sort By:
Page
of 16
Statistics in Medicine
|
April 29, 1998
Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data
J Bernhard, H F Peterson, A S Coates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1994
First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research
M Borner, M Bacchi, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1994
Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group
C Hürny, J Bernhard, A Coates, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group
C Hürny, J Bernhard, R D Gelber, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 26, 1999
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK)
J Bernhard, M Castiglione-Gertsch, S F Schmitz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 20, 1999
Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group
M Colleoni, K Price, M Castiglione-Gertsch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 1999
Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: the SAKK experience. Swiss Group for Clinical Cancer Research (SAKK)
A D Roth, R Herrmann, R Morant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?
J Bernhard, B Thürlimann, S F Schmitz, et al.
Biological Psychiatry
|
March 15, 1996
No association between alcoholism and multiple polymorphisms at the dopamine D2 receptor gene (DRD2) in three distinct Taiwanese populations
R B Lu, H C Ko, F M Chang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 1996
First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88
B Thürlimann, K Beretta, M Bacchi, et al.
Page
of 16